Developing a nanoparticle-delivered high-efficacy treatment for infantile hemangiomas using a mouse hemangioendothelioma model
Background: Current treatments for infantile hemangiomas have unpredictable outcomes.
The authors' aim was to develop a nanoporphyrin-delivered, high-efficacy treatment for …
The authors' aim was to develop a nanoporphyrin-delivered, high-efficacy treatment for …
TREATMENT OF FAST-GROWING MAXILLOFACIL AREA HEMANGIOMAS IN INFANTS
L Ukhina, S Minaev, A Ivchenko, O Aliyev, G Ivchenko… - old.stgmu.ru
Methods. We have observed 28 children aged from 1 month to 1 year old with maxillofacial
hemangiomas of mixed type (size from 1.2 to 5.0 cm) for the treatment of which the …
hemangiomas of mixed type (size from 1.2 to 5.0 cm) for the treatment of which the …
[CITATION][C] Diagnóstico, manejo e indicações terapêuticas do hemangioma infantil
VC Assunção - Revista Interdisciplinar em Gestão, Tecnologia e …, 2018
